secwatch.observer — SEC 8-K summary
======================================

Issuer:     VIEMED HEALTHCARE, INC. (VMD)
CIK:        0001729149
Form:       8-K
Filed at:   2023-03-02T23:59:59+00:00
Accession:  0001729149-23-000039
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Viemed Healthcare reports Q4 2022 core revenue of $37.5M, up 30% YoY; full-year adjusted EBITDA $30.0M
--------------------------------------------------------------------------------

- Q4 core net revenue $37.5M (record), +30% vs Q4 2021, +5% sequentially.
- Full-year 2022 net revenue $138.8M, including $2.3M COVID-related services.
- Q4 net income $2.4M; full-year net income $6.2M.
- Adjusted EBITDA Q4 $9.3M; full-year $30.0M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729149/000172914923000039/0001729149-23-000039-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729149/000172914923000039/vmd-20230302.htm
  HTML page:      https://secwatch.observer/filing/0001729149-23-000039

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer